Vallon Pharmaceuticals Stock Price

0.58 (12.11%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Vallon Pharmaceuticals Inc VLON NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.58 12.11% 5.37 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.76 4.71 5.4593 5.34 4.79
Bid Price Ask Price Spread News
5.37 5.79 0.42 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,942 405,250 $ 5.24 $ 2,124,284 108,183 3.61 - 8.3837
Last Trade Time Type Quantity Stock Price Currency
19:56:19 1 $ 5.37 USD

Vallon Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 36.58M 6.81M 4.19M $ 100.00k $ - -0.78 -4.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 311.99k 3.30%

more financials information »

Vallon Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VLON Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.80355.45934.504.90111,0200.566511.79%
1 Month3.806.493.7194.75157,2711.5741.32%
3 Months4.706.493.614.6484,7970.6714.26%
6 Months8.278.38373.615.4689,988-2.90-35.07%
1 Year8.278.38373.615.4689,988-2.90-35.07%
3 Years8.278.38373.615.4689,988-2.90-35.07%
5 Years8.278.38373.615.4689,988-2.90-35.07%

Vallon Pharmaceuticals Description

Vallon Pharmaceuticals Inc is a biopharmaceutical company primarily focused on the development and commercialization of proprietary biopharmaceutical products. The company develops prescription drugs for central nervous system disorders. Its product ADAIR, a proprietary, abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder, and narcolepsy.

Your Recent History
Vallon Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.